MetaCap

AbbVie Statistics

NYSE: ABBVHealth CareBiotechnology: Pharmaceutical PreparationsUSD

286.20+2.66 (+0.94%)

At close: Nov 20, 4:02 PM ET · Delayed 15 min

AbbVie by the numbers

AbbVie has a market capitalization of $505.89 billion based on 1.77B shares outstanding. Its trailing P/E ratio is 49.2, above the 8-company peer median of 35.8, and its forward P/E is 17.6. The stock trades 2.6% above its 50-day average and 18.0% above its 200-day average.

Average daily trading volume is 4.84M shares, or about $1.39 billion in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ABBV valuation vs. peer median

ABBV compared with the median of 8 peer companies
MetricABBVPeer medianDifference
Market cap$505.89B$224.40B+125%
P/E (TTM)49.235.8+37%
Forward P/E17.615.3+16%
Dividend yield2.42%2.51%-4%
Avg. volume4.84M8.09M-40%

Peer median across 8 companies: JNJ, MRK, NVS, AZN, ABT, NVO, PFE, VRTX.

Valuation

Market cap
$505.89B
Price / sales (latest FY)
8.27

Price and trading

Previous close
283.54
Open
286.83
Day range
284.85 – 290.23
52-week range
190.75 – 302.93
52-week change
+21.13%
Beta
—
Volume
8.76M

Dividends and events

Annual dividend
$6.92
Next earnings date
Oct 30, 2026

Additional statistics

Market Cap
505.89B
Pe
49.18
Forward Pe
17.65
Eps
5.82
Dividend Yield
2.42%
Dividend Rate
6.92
Week52 High
302.93
Week52 Low
190.75
Avg Volume
4.84M
Shares Outstanding
1.77B
Ma50
279.00
Ma200
242.45
Earnings Date
Oct 30, 2026
Pct From52w High
-5.52%
Pct From52w Low
50.04%

Related